Amicus Therapeutics, Inc. logo

Amicus Therapeutics, Inc.

NASDAQ:FOLD

Overview | Financials
Company Name Amicus Therapeutics, Inc.
Symbol FOLD
Currency USD
Price 9.21
Market Cap 2,752,003,260
Dividend Yield 0%
52-week-range 8.79 - 14.03
Industry Biotechnology
Sector Healthcare
CEO Mr. Bradley L. Campbell M.B.A.
Website https://amicusrx.com

An error occurred while fetching data.

About Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in

Related Stocks

Canopy Growth Corporation logo

Canopy Growth Corporation

CGC

2.22 USD

Fate Therapeutics, Inc. logo

Fate Therapeutics, Inc.

FATE

1.255 USD

AbCellera Biologics Inc. logo

AbCellera Biologics Inc.

ABCL

2.77 USD

Corcept Therapeutics Incorporated logo

Corcept Therapeutics Incorporated

CORT

51.66 USD

Allscripts Healthcare Solutions, Inc. logo

Allscripts Healthcare Solutions, Inc.

MDRX

9.25 USD

Alignment Healthcare, Inc. logo

Alignment Healthcare, Inc.

ALHC

13.51 USD

Arvinas, Inc. logo

Arvinas, Inc.

ARVN

17.22 USD

Tilray Brands, Inc. logo

Tilray Brands, Inc.

TLRY

1.18 USD

PTC Therapeutics, Inc. logo

PTC Therapeutics, Inc.

PTCT

41.81 USD

Beam Therapeutics Inc. logo

Beam Therapeutics Inc.

BEAM

23.3 USD

Financials

Numbers are in millions USD

Numbers are in millions USD